Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

Articles published in
Br J Cancer
    August 2022
  1. YU K, Gu Y, Zhang P, Fang H, et al
    Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer.
    Br J Cancer. 2022 Aug 24. pii: 10.1038/s41416-022-01939.
    >> Share

  2. CUI K, Yao S, Liu B, Sun S, et al
    A novel high-risk subpopulation identified by CTSL and ZBTB7B in gastric cancer.
    Br J Cancer. 2022 Aug 8. pii: 10.1038/s41416-022-01936.
    >> Share

    June 2022
  3. RABBANI S, Santoni G, Lagergren J, Xie SH, et al
    Use of anti-androgenic 5alpha-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site.
    Br J Cancer. 2022 Jun 17. pii: 10.1038/s41416-022-01872.
    >> Share

    May 2022
  4. YAO X, He Z, Qin C, Zhang P, et al
    Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisation.
    Br J Cancer. 2022 May 30. pii: 10.1038/s41416-022-01834.
    >> Share

  5. ZANG WJ, Hu YL, Qian CY, Feng Y, et al
    HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3.
    Br J Cancer. 2022 May 30. pii: 10.1038/s41416-022-01805.
    >> Share

  6. ALICANDRO G, Bertuccio P, Collatuzzo G, Pelucchi C, et al
    The mediating role of combined lifestyle factors on the relationship between education and gastric cancer in the Stomach cancer Pooling (StoP) Project.
    Br J Cancer. 2022 May 27. pii: 10.1038/s41416-022-01857.
    >> Share

  7. MARTIMIANAKI G, Alicandro G, Pelucchi C, Bonzi R, et al
    Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium.
    Br J Cancer. 2022 May 24. pii: 10.1038/s41416-022-01856.
    >> Share

    February 2022
  8. ZHENG J, Gao Y, Xie SH, Santoni G, et al
    Correction: Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis.
    Br J Cancer. 2022 Feb 24. pii: 10.1038/s41416-022-01761.
    >> Share

  9. DALMARTELLO M, Turati F, Zhang ZF, Lunet N, et al
    Allium vegetables intake and the risk of gastric cancer in the Stomach cancer Pooling (StoP) Project.
    Br J Cancer. 2022 Feb 24. pii: 10.1038/s41416-022-01750.
    >> Share

  10. LI Y, Liu C, Zhang X, Huang X, et al
    CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/beta-catenin signalling pathway.
    Br J Cancer. 2022 Feb 22. pii: 10.1038/s41416-022-01747.
    >> Share

    January 2022
  11. ZHENG J, Gao Y, Xie SH, Santoni G, et al
    Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis.
    Br J Cancer. 2022 Jan 13. pii: 10.1038/s41416-021-01693.
    >> Share

    December 2021
  12. ADIB E, El Zarif T, Nassar AH, Akl EW, et al
    CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
    Br J Cancer. 2021 Dec 23. pii: 10.1038/s41416-021-01673.
    >> Share

    November 2021
  13. CHEN K, Gu Y, Cao Y, Fang H, et al
    TIM3(+) cells in gastric cancer: clinical correlates and association with immune context.
    Br J Cancer. 2021 Nov 1. pii: 10.1038/s41416-021-01607.
    >> Share

    October 2021
  14. SHIMURA T, Kandimalla R, Okugawa Y, Ohi M, et al
    Novel evidence for m(6)A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer.
    Br J Cancer. 2021 Oct 21. pii: 10.1038/s41416-021-01581.
    >> Share

  15. KOHLRUSS M, Krenauer M, Grosser B, Pfarr N, et al
    Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.
    Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01587.
    >> Share

  16. BAXTER MA, Middleton F, Cagney HP, Petty RD, et al
    Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers.
    Br J Cancer. 2021;125:1068-1079.
    >> Share

    July 2021
  17. ZHENG J, Santoni G, Xie SH, Lagergren J, et al
    Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study.
    Br J Cancer. 2021;125:277-283.
    >> Share

    June 2021
  18. LEE IS, Ahn J, Kim K, Okugawa Y, et al
    A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
    Br J Cancer. 2021 Jun 23. pii: 10.1038/s41416-021-01461.
    >> Share

    April 2021
  19. TANAKA H, Kanda M, Miwa T, Umeda S, et al
    G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer.
    Br J Cancer. 2021 Apr 14. pii: 10.1038/s41416-021-01366.
    >> Share

    March 2021
  20. TAKASHIMA T, Taniyama D, Sakamoto N, Yasumoto M, et al
    Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.
    Br J Cancer. 2021 Mar 30. pii: 10.1038/s41416-021-01364.
    >> Share

  21. LI Z, Wu X, Gao X, Shan F, et al
    Development and validation of a novel staging system integrating the number and location of lymph nodes for gastric adenocarcinoma.
    Br J Cancer. 2021;124:942-950.
    >> Share

    February 2021
  22. MIWA T, Kanda M, Shimizu D, Umeda S, et al
    Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway.
    Br J Cancer. 2021 Feb 3. pii: 10.1038/s41416-021-01271.
    >> Share

    October 2020
  23. SAITO R, Shoda K, Maruyama S, Yamamoto A, et al
    Platelets enhance malignant behaviours of gastric cancer cells via direct contacts.
    Br J Cancer. 2020 Oct 28. pii: 10.1038/s41416-020-01134.
    >> Share

  24. YAMASHITA K, Iwatsuki M, Yasuda-Yoshihara N, Morinaga T, et al
    Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer.
    Br J Cancer. 2020 Oct 26. pii: 10.1038/s41416-020-01138.
    >> Share

  25. OPENSHAW MR, Mohamed AA, Ottolini B, Fernandez-Garcia D, et al
    Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma.
    Br J Cancer. 2020;123:1271-1279.
    >> Share

    September 2020
  26. ZHAO J, Fu X, Chen H, Min L, et al
    G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer.
    Br J Cancer. 2020 Sep 29. pii: 10.1038/s41416-020-01067.
    >> Share

  27. JUNTTILA A, Helminen O, Vayrynen JP, Ahtiainen M, et al
    Immunophenotype based on inflammatory cells, PD-1/PD-L1 signalling pathway and M2 macrophages predicts survival in gastric cancer.
    Br J Cancer. 2020 Sep 18. pii: 10.1038/s41416-020-01053.
    >> Share

  28. SHIMURA T, Dayde D, Wang H, Okuda Y, et al
    Novel urinary protein biomarker panel for early diagnosis of gastric cancer.
    Br J Cancer. 2020 Sep 16. pii: 10.1038/s41416-020-01063.
    >> Share

    July 2020
  29. HAGI T, Kurokawa Y, Kawabata R, Omori T, et al
    Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer.
    Br J Cancer. 2020 Jul 3. pii: 10.1038/s41416-020-0975.
    >> Share

  30. LIN JX, Yoon C, Li P, Ryeom SW, et al
    CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancer.
    Br J Cancer. 2020 Jul 1. pii: 10.1038/s41416-020-0963.
    >> Share

    June 2020
  31. KIM JH, Han KD, Lee JK, Kim HS, et al
    Correction: Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality.
    Br J Cancer. 2020 Jun 17. pii: 10.1038/s41416-020-0946.
    >> Share

    May 2020
  32. LIN JP, Lin JX, Ma YB, Xie JW, et al
    Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer.
    Br J Cancer. 2020 May 26. pii: 10.1038/s41416-020-0901.
    >> Share

  33. NATSUME M, Shimura T, Iwasaki H, Okuda Y, et al
    Omental adipocytes promote peritoneal metastasis of gastric cancer through the CXCL2-VEGFA axis.
    Br J Cancer. 2020 May 22. pii: 10.1038/s41416-020-0898.
    >> Share

  34. KIM JH, Han KD, Lee JK, Kim HS, et al
    Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality.
    Br J Cancer. 2020 May 13. pii: 10.1038/s41416-020-0883.
    >> Share

  35. LIU P, McMenamin UC, Johnston BT, Murchie P, et al
    Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies.
    Br J Cancer. 2020 May 5. pii: 10.1038/s41416-020-0860.
    >> Share

    April 2020
  36. GAO Y, Li J, Xi H, Cui J, et al
    Stearoyl-CoA-desaturase-1 regulates gastric cancer stem-like properties and promotes tumour metastasis via Hippo/YAP pathway.
    Br J Cancer. 2020 Apr 30. pii: 10.1038/s41416-020-0827.
    >> Share

  37. LIU HT, Ma RR, Lv BB, Zhang H, et al
    LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer.
    Br J Cancer. 2020 Apr 27. pii: 10.1038/s41416-020-0836.
    >> Share

    March 2020
  38. LI R, Liu H, Cao Y, Wang J, et al
    Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103(+)CD8(+) T cells conferring favourable prognosis.
    Br J Cancer. 2020 Mar 24. pii: 10.1038/s41416-020-0813.
    >> Share

  39. WU C, Ding H, Wang S, Li Y, et al
    DAXX inhibits cancer stemness and epithelial-mesenchymal transition in gastric cancer.
    Br J Cancer. 2020 Mar 23. pii: 10.1038/s41416-020-0800.
    >> Share

  40. OHMURA H, Yamaguchi K, Hanamura F, Ito M, et al
    OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.
    Br J Cancer. 2020 Mar 23. pii: 10.1038/s41416-020-0810.
    >> Share

  41. KWAK Y, Koh J, Park Y, Hong YJ, et al
    Differential prognostic impact of CD8(+) T cells based on human leucocyte antigen I and PD-L1 expression in microsatellite-unstable gastric cancer.
    Br J Cancer. 2020 Mar 17. pii: 10.1038/s41416-020-0793.
    >> Share

    November 2019
  42. ICHIKAWA T, Okugawa Y, Toiyama Y, Tanaka K, et al
    Clinical significance and biological role of L1 cell adhesion molecule in gastric cancer.
    Br J Cancer. 2019 Nov 22. pii: 10.1038/s41416-019-0646.
    >> Share

    October 2019
  43. MASHIMA T, Iwasaki R, Kawata N, Kawakami R, et al
    In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells.
    Br J Cancer. 2019 Oct 14. pii: 10.1038/s41416-019-0600.
    >> Share

    July 2019
  44. COATI I, Lotz G, Fanelli GN, Brignola S, et al
    Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.
    Br J Cancer. 2019;121:257-263.
    >> Share

    June 2019
  45. ZHENG J, Rutegard M, Santoni G, Wallner B, et al
    Prediabetes and diabetes in relation to risk of gastric adenocarcinoma.
    Br J Cancer. 2019;120:1147-1152.
    >> Share

    March 2019
  46. KIM JH, Eom HJ, Lim G, Park S, et al
    Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 alpha inhibitor BI6015.
    Br J Cancer. 2019;120:488-498.
    >> Share

  47. FORNARO L, Vivaldi C, Parnofiello A, Ugolini C, et al
    Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.
    Br J Cancer. 2019;120:522-526.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016